334 related articles for article (PubMed ID: 18518782)
1. Treatment strategies for pemphigus vulgaris in Japan.
Hashimoto T
Expert Opin Pharmacother; 2008 Jun; 9(9):1519-30. PubMed ID: 18518782
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of pemphigus.
Tsuruta D; Ishii N; Hashimoto T
Immunotherapy; 2012 Jul; 4(7):735-45. PubMed ID: 22853759
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab).
Kong HH; Prose NS; Ware RE; Hall RP
Pediatr Dermatol; 2005; 22(5):461-4. PubMed ID: 16191003
[TBL] [Abstract][Full Text] [Related]
4. Seeking approval: present and future therapies for pemphigus vulgaris.
Mao X; Payne AS
Curr Opin Investig Drugs; 2008 May; 9(5):497-504. PubMed ID: 18465660
[TBL] [Abstract][Full Text] [Related]
5. [Pemphigus].
Lapeyre-LiƩnard H; Joly P
Presse Med; 2010 Oct; 39(10):1066-70. PubMed ID: 20817387
[TBL] [Abstract][Full Text] [Related]
6. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab).
Morrison LH
J Am Acad Dermatol; 2004 Nov; 51(5):817-9. PubMed ID: 15523367
[TBL] [Abstract][Full Text] [Related]
7. Novel Therapies for Pemphigus Vulgaris.
Altman EM
Am J Clin Dermatol; 2020 Dec; 21(6):765-782. PubMed ID: 32860200
[TBL] [Abstract][Full Text] [Related]
8. The actual management of pemphigus.
Daniel BS; Murrell DF
G Ital Dermatol Venereol; 2010 Oct; 145(5):689-702. PubMed ID: 20930702
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): five cases.
Antonucci A; Negosanti M; Tabanelli M; Varotti C
J Dermatolog Treat; 2007; 18(3):178-83. PubMed ID: 17538808
[TBL] [Abstract][Full Text] [Related]
10. Immunoadsorption in the treatment of pemphigus.
Mlynek A; Meurer M
Atheroscler Suppl; 2009 Dec; 10(5):107-9. PubMed ID: 20129386
[TBL] [Abstract][Full Text] [Related]
11. Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris.
Faurschou A; Gniadecki R
Int J Dermatol; 2008 Mar; 47(3):292-4. PubMed ID: 18289336
[TBL] [Abstract][Full Text] [Related]
12. Pemphigus vulgaris: approach to treatment.
Sinha AA; Hoffman MB; Janicke EC
Eur J Dermatol; 2015 Apr; 25(2):103-13. PubMed ID: 25547117
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.
Allen KJ; Wolverton SE
J Drugs Dermatol; 2007 Sep; 6(9):883-9. PubMed ID: 17941359
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Kim MR; Kim HC; Kim SC
Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
[TBL] [Abstract][Full Text] [Related]
15. [Pemphigus: a review].
Joly P; Sin C
Ann Dermatol Venereol; 2011 Mar; 138(3):182-200. PubMed ID: 21397148
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder.
Salopek TG; Logsetty S; Tredget EE
J Am Acad Dermatol; 2002 Nov; 47(5):785-8. PubMed ID: 12399777
[TBL] [Abstract][Full Text] [Related]
17. Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?
Tavakolpour S
Int Immunopharmacol; 2017 Dec; 53():133-142. PubMed ID: 29107213
[TBL] [Abstract][Full Text] [Related]
18. Current therapy of the pemphigus group.
Kasperkiewicz M; Schmidt E; Zillikens D
Clin Dermatol; 2012; 30(1):84-94. PubMed ID: 22137231
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pemphigus vulgaris: current and emerging options.
Yeh SW; Sami N; Ahmed RA
Am J Clin Dermatol; 2005; 6(5):327-42. PubMed ID: 16252932
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M
J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]